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INTRODUCTION
Inorganic phosphate (Pi) homeostasis in the body is mediated
by the absorption of dietary Pi in the small intestine, reabsorption
from the urine into the kidney, and bone formation/resorption.
Type II Na+ -dependent Pi (NaPi) cotransporters (SLC34A1/Npt2a/
NaPi-IIa, and SLC34A3/Npt2c/NaPi-IIc) and type III NaPi cotrans-
porter (PiT-2/Slc20a2) are expressed at the apical membrane of
the proximal tubular cells and mediate Pi transport (1, 2). Type II
NaPi transporters in the renal proximal tubules mediate the rate-
limiting step in overall -Pi reabsorption (3, 4). The type II NaPi
family comprises electrogenic NaPi-IIa/b and electroneutral NaPi-
IIc, which have Na+ : Pi cotransport stoichiometries of 3 : 1 and
2 : 1, respectively (5, 6). NaPi-IIa and NaPi-IIc are major functional
transporters in the apical membrane of the proximal tubular cells
(1, 2). In rodents, NaPi-IIa is the most important renal Pi cotrans-
porter, and NaPi-IIa-knockout (KO) mice have hypophosphatemia
and hyperphosphaturia (7). In contrast, NaPi -IIc is a major func-
tional NaPi cotransporter in the human kidney, because NaPi-IIc
mutations cause hereditary hypophosphatemic rickets with hyper-
calciuria (HHRH) (8, 9). Individuals affected by HHRH who carry
compound heterozygous or homozygous (com/hom) NaPi-IIc mu-
tations exhibit increased urinary Pi excretion, leading to hypophos-
phatemic rickets, bowing, and short stature, as well as elevated
1,25 (OH)2 D3 levels (8-10).
In a previous study using mouse models, we reported that NaPi-
IIc plays a minor role in renal Pi reabsorption, and that NaPi-IIa
may be able to sufficiently support NaPi cotransport activity to com-
pensate for NaPi-IIc deficiencies in NaPi-IIc-KO mice (1, 11-13).
The marked differences in the phenotypes of NaPi-IIa-KO and
NaPi-IIc-KO mice may be due to the differential dominance in
transporters for Pi homeostasis (7, 13, 14). Indeed, kidney expres-
sion of NaPi-IIc is high during weaning, but lower in adult animals
(1, 11, 12). Furthermore, expression of NaPi-IIa transcripts is re-
stricted to the proximal tubules (15), while NaPi-IIc transcripts are
expressed in various tissues (e.g. intestine, spleen, testis, uterus,
placenta, bone, and brain) (16).
Renal Pi transport is regulated by changes in the abundance of
NaPi-IIa and NaPi-IIc proteins in the brush border membrane,
and involves their interaction with scaffolding and signaling pro-
teins essential to their brush border membrane insertion, retrieval,
and degradation (2). Regulation by NaPi-IIc has been studied in
less detail, however, because renal proximal tubular cells that ex-
press endogenous NaPi-IIc protein are not available.
Cellular cascades involved in the “physiologic/pathophysiologic”
control of Pi reabsorption have been explored in a tissue culture
model (opossum kidney [OK] cells) expressing intrinsic NaPi-IIa
(NaPi-4) (17-21). As OK cells provide a “proximal tubular” envi-
ronment, this tissue culture model is useful for characterizing (in
heterologous expression studies) the cellular/molecular require-
ments for transport regulation (2). In previous studies, we investi-
gated NaPi-IIc regulation in a heterologous expression system of
OK cells (22, 23). In the present study, we created specific antibod-
ies to opossum NaPi-IIc (oNaPi-IIc) and analyzed their localization.
The levels of oNaPi-IIc protein were increased in proliferative cells,
but not in differentiated cells. We discuss the physiological roles
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of endogenous NaPi-IIc in OK cells.
MATERIALS AND METHODS
Plasmid constructs.
Full - length wild- type (WT) human NaPi-IIc, mouse NaPi-IIc,
human NaPi-IIa, and mouse NaPi-IIb with a FLAG tag (pCMV-
Tag2A vector ; Stratagene, La Jolla, CA ; FLAG-NaPi-IIc) or an en-
hanced green fluorescent protein (EGFP) tag (pEGFP-C1 vector ;
Clontech, Palo Alto, CA ; EGFP-NaPi-IIa, EGFP-NaPi-IIc) or a
mCherry tag (pmCherry-C1 vector ; Clontech ; mCherry-NaPi-
IIc) at the NH2 terminus were generated using standard cloning
techniques (20, 22). PCR and a site -directed mutagenesis kit (Quik-
Change Lightning site -directed mutagenesis kit, Stratagene) were
used to introduce the S138F and R468W mutations into EGFP-
human NaPi-IIc WT, as previously described (23), and the S189
A, S191A, and G195D (electrogenic mutant) into EGFP- or FLAG-
mouse NaPi-IIc WT (24). All human NaPi-IIc mutant cDNAs were
subcloned into pCMV-Tag2A (Stratagene) for Pi uptake assays.
Mouse NaPi-IIc electrogenic mutant constructs were confirmed
by the following sequencing : S189A, S191A, G195D, 5’ -cagaggg-
ccttcgccggcgcggccgtgcatg-3’ (sense), 5’ -catgcacggccgcgccggcg-
aaggccctctg-3’ (antisense), and 5’ -cgcggccgtgcatgacatcttcaactg-
gc-3’ (sense), 5’ -gccagttgaagatgtcatgcacggccgcg-3’ (antisense).
PLCδ1PH domain-pEGFP-C1 (PLCδPH-EGFP) was kind gift from
Dr. M. Isshiki (University of Tokyo, Tokyo, Japan) (25, 26).
Animals.
Mice were maintained under pathogen-free conditions and han-
dled in accordance with the Guidelines for Animal Experimenta-
tion of Tokushima University School of Medicine. Male C57BL/
6J mice were purchased from Charles River Laboratories Japan
(Yokohama, Japan). NaPi-IIa KO mice were purchased from Jack-
son Laboratories (Bar Harbor, ME). The generation of NaPi-IIc
KO mice was described previously (13).
Cell culture and plasmid transfection.
OK cells were obtained from the American Type Culture Col-
lection (ATCC ; Rockville, MD) and 3B/2 clones were a kind gift
from Dr. J. Biber (Zurich University, Switzerland, Switzerland).
The OK cells were maintained in an appropriate medium (20). For
live cell imaging, 1.4105 cells/dish were plated in 35-mm glass-
base dishes (Iwaki, Chiba, Japan) and subconfluent cultures were
transfected with each EGFP- or mCherry- fused construct. For im-
munostaining, 0.5105 cells/well were plated on glass coverslips
(Matsunami-glass, Osaka, Japan) in 12-well dishes, and subcon-
fluent cultures were transfected with a FLAG-fused construct.
Transfections were performed for 24 h using LipofectAMINE
2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s
instructions. For Western blotting analysis, 1.4105 cells/well were
plated in six-well dishes, and total cell lysates were prepared on
days 2, 3, 4, and 6 after seeding.
Reverse transcription-PCR analysis.
Total RNA was prepared from OK cells using ISOGEN (Nippon
Gene, Tokyo, Japan) (22). cDNA was synthesized using the Moloney
murine leukemia virus, reverse transcriptase (Superscript, Invitro-
gen), and Oligo (dT) 12-18 Primer. PCR was initiated with denatu-
ration at 98for 3 min, followed by amplification at 95for 30 s,
57-60for 30 s, and 72for 30 s for 25 to 35 cycles. Primers used
in this study are listed in Table 1.
Pi uptake studies in OK cells.
Pi transport was studied in monolayers of OK cells transfected
with each FLAG-fused construct in 12-well dishes. Uptake experi-
ments were performed as previously described (22, 23). In brief,
Pi uptake studies were carried out in uptake solution containing
137 mM NaCl, 5.4 mM KCl, 2.8 mM CaCl2, 1.2 mM MgSO4, 10
mM HEPES-Tris (pH 7.4), 0.1 mM KH2PO4/K2HPO4, and 1 μCi/
ml 32P (PerkinElmer, Bridgeport, CT) at 37. After 6 min, the cells
were washed three times with cold stop solution containing 137
mM NaCl, 10 mM Tris-HCl pH 7.2, 2 mM KH2PO4/K2HPO4 (pH
7.4), and then solubilized by the addition of 0.4 ml of 0.1 N NaOH.
Insta-Gel Plus (PerkinElmer) was added to the cell lysates. 32P
levels in cell lysates were determined using a bicinchoninic acid
assay protein assay kit (Pierce, Rockford, IL). Pi transport was cal-
culated as nanomoles 32P per milligram protein taken up in 6 min.
These experiments were performed in triplicate and repeated two
to four times.
Preparation of rabbit polyclonal anti-oNaPi-IIc antibody.
An amino acid peptide sequence from the carboxyl - terminal
(CFENPVVLASQRL) of oNaPi-IIc was fused to keyhole limpet
hemocyanin, and used to generate rabbit polyclonal antibody by
Medical and Biological Laboratories (Aichi, Japan) (22, 23).
Confocal microscopy analysis.
Cells were imaged using an A1R confocal laser scanning micro-
scope system (Nikon, Tokyo, Japan) equipped with a 60oil im-
mersion objective. Immunostaining was performed as described
previously (22, 23). For protein detection, cells were incubated
with anti -NaPi -4 (oNaPi-IIa) polyclonal (1 : 100), anti -oNaPi-IIc
polyclonal (1 : 100), or anti -FLAG-M2 monoclonal antibody (Sigma,
1 : 250). Alexa Fluor 568-Phalloidin (Molecular Probes, Eugene,
OR ; 1 : 100) was used for the detection of actin. Alexa Fluor 488-
conjugated mouse IgG (Molecular Probes, 1 : 100), or Alexa Fluor
488-conjugated rabbit IgG (Molecular Probes, 1 : 100) was used
as the secondary antibody. Coverslips were mounted with Aqua
PolyMount (Polysciences, Warrington, PA).
Table 1
primers used in this study
Gene Sense (5’ - 3’) Antisense (5’ - 3’) Productsize (bp) Reference
RT-PCR oNaPi - IIa GCTGGCTCCCTTACCCTACTG GATGACTGTCTGGACCACCTTG 102 L26308 (NCBI Nucleotide)
oNaPi - IIc GGTGGTGGGAGCCTTTACTC TTTGGTCATGTTGCCTGTGG 139 XM_007475445
PiT -1 GGTGGGAACGATGTCAGCAA ACCAACGCCACCATACAACA 123 XM_007477569
PiT -2 TGATACCACCATTCCCCTCA AACCGTGCGTCATGGAAAG 119 XM_001373110
Megalin AGGCTCCCTTCTGCCATCTCTTC GCAGAATCTGGTCCAAAACCTGACAC 144 Endocrinology. 2009 Feb ; 150(2) :871 -8.
GAPDH CTGCACCACCAACTGCTTAGC GCCTGCTTCACCACCTTCTTG 342 Am J Physiol Renal Physiol 2010Jul : 299(1) : F243 -54.
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Preparation of total cell lysates.
Proteins were isolated as described previously (22, 23). OK cells
were rinsed twice with ice-cold Tris-buffered saline, scraped off
in the isolation buffer (0.5% nonidet P-40, 1 mM PMSF, 2 μg/ml
aprotinin, and 2 μg/ml leupeptin in Tris-buffered saline (pH 7.5)
and resuspended five times using a 20-gauge needle. Homogen-
ates were centrifuged at 10,000g for 2 min, and supernatants
were collected in new tubes. The protein concentration in the
lysates was determined using a bicinchoninic acid protein assay
kit (Pierce) and analyzed by Western blotting.
Preparation of BBMV and whole homogenate for immunoblotting.
Brush border membrane vesicles (BBMVs) were prepared from
the kidneys from the mice using the Ca2+ precipitation methods
described as previously (13, 27). Kidney was sliced and thoroughly
homogenized in homogenate buffer (5 mM Tris-HCl/ pH 7.5, 250
mM sucrose, 0.1 mM phenylmethylsulfonyl fluoride). The homo-
genate was centrifuged at 3000 rpm for 10 minutes. The superna-
tant was used for whole homogenate sample.
Immunoblot analysis.
Cells grown on 6-wells were transfected as described above and
previously (22, 23). In brief, equivalent amounts of protein samples
were heated at 95 for 3 min in sample buffer containing 5% 2-
mercaptoethanol, subjected to 9% SDS-PAGE, and transferred elec-
trophoretically to polyvinylidene difluoride transfer membranes
(Immobilon-P ; Millipore, Billerica, MA). Membranes were incu-
bated in 5% skim milk in 20 mM Tris-HCl (pH 7.5), 150 mM NaCl,
and 0.1% Tween 20 (TBST) at room temperature for 1 h to inhibit
nonspecific binding, and then overnight at 4 with anti -oNaPi-IIc
polyclonal (1 : 2000), anti -NaPi -4 (oNaPi-IIa) polyclonal (1 : 2000),
anti -mouse NaPi-IIc polyclonal (1 : 1500), anti -proliferating cell
nuclear antigen (PCNA) monoclonal (Sigma, P8825, 1 : 15000),
anti -opossum Megalin polyclonal (a kind gift from Dr. A. Saito,
Niigata University, Niigata, Japan ; 1 : 1000) (28) or anti -actin mon-
oclonal antibody (Chemicon, Temecula, CA ; used as an internal
control, 1 : 10000), in 1% skim milk in TBST, followed by treatment
with horseradish peroxidase-conjugated secondary antibody (Jack-
son ImmunoResearch, West Grove, PA ; 1 : 10000). Signals were de-
tected using the Immobilon Western detection system (Millipore).
Statistics.
Differences among multiple groups were analyzed by ANOVA.
A P value of less than 0.05 was considered statistically significant.
RESULTS
Expression of NaPi-IIc protein in OK cells.
To investigate the expression of endogenous oNaPi-IIc protein
in OK cells by Western blot, we produced polyclonal antibodies
against the oNaPi-IIc carboxyl - terminus (C-terminus). Full length
amino acid sequence of type IIc NaPi transporters in opossum (gray
short - tailed opossum, NCBI Reference Sequence, XP_007475507.1)
and human (NP_001170787.1) are 69% homologous. Furthermore,
the amino acid sequence of the oNaPi-IIc C-terminus is highly
conserved among mouse, human, and opossum (Fig. 1A), and
XP_007475507.1 was used as the oNaPi-IIc amino acid sequence.
The oNaPi-IIc protein was detected as80 kDa protein in OK
cells (Fig. 1B). Anti -oNaPi-IIc antibody specificity was confirmed
by the absence of bands of80 kDa in the competition assay using
antibody incubated with antigen peptide (Fig. 1B). In contrast,
HeLa cells did not express endogenous NaPi-IIc protein, based
on Western blot analysis (data not shown). In addition, NaPi-IIc
protein in wild- type (WT) and NaPi-IIa KO mouse kidney was
recognized by anti -oNaPi-IIc antibody, whereas in NaPi-IIc KO
mouse was not detected by anti -oNaPi-IIc antibody (Fig. 1C).
Fig. 1
Production and characterization of anti -oNaPi - IIc antibody A Alignment of the C-terminus 13-amino acid sequence of NaPi - IIc (opossum, mouse,
human). B Peptide competition assay. Total cell lysates from OK cells at day 2 after seeding were separated by SDS-PAGE, and the blotted mem-
brane was probed with anti -oNaPi - IIc antibody, which was preincubated for 1 h at room temperature with (+) or without ( -) recombinant fragments
corresponding to the 13-amino acid of the oNaPi - IIc C- terminus, as indicated. CWestern blotting analysis using renal BBMV isolated from the
kidney of WT, NaPi - IIc -KO (NaPi - IIc -/ -), and NaPi - IIa -KO (NaPi - IIa -/ -) mice by opossum and mouse NaPi - IIc antibodies. Actin was used as
an internal control.
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We then investigated the expression of endogenous oNaPi-IIa
and oNaPi-IIc proteins during cell proliferation and differentiation.
Total cell lysates and total mRNAs were obtained on days 2, 3, 4,
and 6 after cell seeding (Fig. 2A). Microscopy analysis revealed
that OK cells were sub-confluent at day 2, confluent at day 3, and
formed domes (characteristic of proximal tubular cells) on day 5
(data not shown). Based on RT-PCR analysis, oNaPi-IIa (NaPi-4)
mRNA levels increased throughout the differentiation phase (days
4, 6 ; Fig. 2B). The levels of Megalin mRNA, a marker of the dif-
ferentiation of proximal tubular cells with a time-course of induc-
tion similar to that of oNaPi-IIa, were increased in OK cells on days
4 and 6 (Fig. 2B). oNaPi-IIc mRNA levels were also abundant in
the differentiated phase (Fig. 2B). The PiT-1 and PiT-2 mRNA lev-
els were unchanged in between proliferative and differentiated cells
(Fig. 2B). Moreover, Pi transport activity was higher in the differ-
entiated phase than in the proliferative phase (Fig. 2C). By West-
ern blot analysis, expression of oNaPi-IIa protein was only detected
in the differentiated phase (days 4, 6), and not the proliferative
phase (days 2, 3) (Fig. 2D). Similarly to oNaPi-IIa protein expres-
sion, Megalin levels were higher in differentiated cells (days 4, 6)
than in proliferative cells (days 2, 3 ; Fig. 2D). These observations
are consistent with several previous reports (29). In contrast, the
80 kDa protein bands of oNaPi-IIc protein were detected in the
proliferative phase, and not in the differentiated phase (Fig. 2D).
The oNaPi-IIc protein levels correlated with the expression of
PCNA protein, which is a marker of the proliferative phase. Con-
focal microscopy revealed co- localization of the immunoreactive
signals of oNaPi-IIa protein with F-actin at the apical patch in dif-
ferentiated cells (day 6) (Fig. 2E), while immunoreactive signals
of oNaPi-IIa were not detected in proliferative cells (day 2). In con-
trast, immunoreactive signals of oNaPi-IIc protein localized at the
membrane protrusion (lamellipodia and cell membrane ruffles) at
the leading edge of proliferative cells (day 2), and not in differen-
tiated cells (day 6 ; Fig. 2E). Overexpressed human NaPi-IIc pro-
tein also localized at the protrusion (cell membrane ruffles, Fig. 2F)
and induced cellular vacuoles (data not shown).
Effect of cell cycle synchronization and release on NaPi-II ex-
pression.
We then analyzed the expression of oNaPi-IIc in OK cells that
were synchronized by serum starvation (for 2 days), and then re-
leased by serum re-feeding for 4, 8, 12, 16, 20, and 24 h (Fig. 3A).
The cell cycle profiles were analyzed by flow-cytometry (Fig. 3B).
The rates of cells in G0/G1 phases were increased by serum star-
vation, and the rates of cells in S+G2/M phases were increased in
cells with serum re-feeding after serum starvation (Fig. 3B). oNaPi-
IIa protein levels were increased in serum-starved cells synchro-
nized in the G0/G1 phase, and downregulated in serum re-fed cells
entering the cell cycle (Fig. 3B, C). Megalin protein levels were
similar to those of oNaPi-IIa protein (Fig. 3C). In contrast, oNaPi-
IIc protein levels were downregulated in the serum-starved cells,
and increased in the serum re-fed cells (Fig. 3C). These findings
indicate that oNaPi-IIc protein levels increase in proliferative cells
entering the cell cycle in the presence of serum. Immunocytochem-
istry revealed oNaPi-IIa protein signals at apical patches in the
serum-starved cells (Fig. 3D), but not in serum re-fed cells. By
contrast, oNaPi-IIc protein was not observed in serum-starved cells,
but were clearly detected at the plasma membrane (protrusion) and
cellular vesicles in the serum re-fed cells (Fig. 3D). These findings
suggest that oNaPi-IIc is induced by the stimulation of prolifera-
tion in OK cells.
Effect of NaPi-IIc on vacuole formation in OK cells.
Next, we investigated whether NaPi-IIc expression affects the
formation of cell membrane protrusions. As shown in Fig. 4A, over-
expressed human NaPi-IIc, but not human NaPi-IIa or mouse
NaPi-IIb (data not shown), induces the formation of membrane
protrusions and cellular vacuoles. Vacuoles in proximal tubular
cells are often observed as endosomes, which have a role in the en-
docytosis of various substrates, such as albumin, vitamin D-binding
protein, and transferrin (30-32). Endocytosis is regulated by many
phospholipids containing phosphatidylinositol 4,5 -bisphosphate
(PIP2) (33). The oNaPi-IIc localized with PLCδPH-EGFP (PIP2
marker) at the membrane (Fig. 4B), and overexpressed NaPi-IIc
co- localized with PLCδPH-EGFP at the cell surface and in PIP2 -
rich cellular vacuoles (Fig. 4C).
Effect of HHRH mutations on NaPi-IIc function in OK cells.
The oNaPi-IIc localized in the protrusion and cellular vesicles,
and overexpression of NaPi-IIc induced PIP2 -rich vacuoles under
the plasma membrane (Fig. 4B, C). These findings suggest that
NaPi-IIc is involved in PIP2 production. Indeed, overexpression of
PLCδPH-EGFP induces cellular vacuoles as reported previously
(34). We then investigated whether the production of cellular vacu-
oles is due to the properties of NaPi-IIc (electroneutral NaPi co-
transport activity) (24). We constructed the electrogenic NaPi-IIc
mutant as reported previously (24) and analyzed whether electro-
genic NaPi-IIc induces cellular vacuoles in OK cells. Overexpres-
sion of NaPi-IIc (WT) induced Pi transport activity and cellular
vacuoles (Fig. 5A, B). In contrast, electrogenic NaPi-IIc did not
induce the formation of cellular vacuoles in the transfected OK
cells (Fig. 5A, B). These findings indicate that expression of the
electroneutral NaPi cotransporter could induce cellular vacuoles in
OK cells. Moreover, we investigated whether NaPi-IIc with HHRH
mutations affected the formation of cellular vacuoles in OK cells.
The WT human NaPi-IIc markedly increased NaPi cotransport
activities in OK cells, while mutations (S138F, R468W) of NaPi-IIc
markedly suppressed NaPi cotransport activities (Fig. 5C). In ad-
dition, NaPi-IIc WT stimulated the formation of cellular vacuoles,
while NaPi-IIc mutants (S138F and R468W) failed to induce cellu-
lar vacuole formation (Fig. 5D). These findings indicate that NaPi-
IIc with HHRH mutations decreases both vacuole formation and
NaPi cotransport activity.
DISCUSSION
In the present study, we investigated the expression of endoge-
nous NaPi-IIc (oNaPi-IIc) in OK cells using specific antibodies.
Immunoreactive signals of oNaPi-IIc increased in growth condi-
tions and markedly decreased in the differentiated phase. Using
confocal image analysis, we detected immunoreactive signals of
oNaPi-IIc in the plasma membrane and cellular vesicles in undif-
ferentiated OK cells. Regulation of oNaPi-IIc might be involved in
post- translational modification or the control of protein degrada-
tion, based on the high levels of oNaPi-IIc mRNA transcripts in
differentiated OK cells.
Serum starvation prevents the proliferation of various cells and
refeeding of serum stimulates cell proliferation (35). Under these
conditions, the expression profiles of oNaPi-IIa and oNaPi-IIc in
OK cells differed markedly. The oNaPi-IIc levels were increased
by stimulating cell proliferation.
In the proliferative phase, oNaPi-IIc localized in the membrane
protrusion and cellular vesicles. We analyzed the localization in
proliferative OK cells using FLAG-tagged exogenous NaPi-IIc
(human or mouse). The localization of exogenous NaPi-IIc was al-
most identical to that of oNaPi-IIc in OK cells. Exogenous NaPi-
IIc induced cellular vacuoles and localized in the plasma membrane.
These expression patterns were very similar to those of PIP2 ex-
pression, which induces protrusions or membrane vesicle traffick-
ing. Furthermore, the vacuole formation ability may be specific to
NaPi-IIc, but not NaPi-IIa and NaPi-IIb. Indeed, the electrogenic
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NaPi-IIc mutant caused no cellular vacuole formation.
Cell migration involves the transient formation of membrane
protrusions (lamellipodia and cell membrane ruffles) at the lead-
ing edge of the cell ; these are thought to require rapid local changes
in ion fluxes and cell volume (36). We postulated that NaPi-IIc ex-
pression alters the rate of the formation of cell membrane protru-
sions. NaPi-IIc might accelerate cell migration by facilitating the
rapid turnover of cell membrane protrusions at the leading edge.
It has been proposed that actin cleavage and ion uptake at the tip
of a lamellipodium create local ion gradients that drive the influx
of phosphate ions across the cell membrane (36).
HHRH is characterized by hypophosphatemia secondary to renal
Pi wasting, resulting in increased serum 1, 25 (OH)2 D3 concentra-
tions with associated intestinal Ca2+ hyperabsorption, hypercalci-
uria, rickets, and osteomalacia (8-10). In patients with HHRH, the
mechanism underlying the increased vitamin D synthesis in the
proximal tubules is unknown. It is reported that vitamin D synthe-
sis increases due to endocytic abnormalities in the renal proximal
Fig. 2
Expression of NaPi -4 (oNaPi - IIa) and endogenous oNaPi - IIc in OK cells. A Schematic of the experiment schedule. OK cells were plated, and total
cell lysates or total mRNAs were prepared on days 2, 3, 4, and 6 after seeding. B Levels of oNaPi - IIa and oNaPi - IIc and type III NaPi cotransporter
(PiT-1 and PiT-2) mRNAs were assessed by RT-PCR analysis. Gapdh mRNA was amplified as an internal control. CMonolayers of OK cells were
seeded in 12-well dishes, and Pi uptake was examined on days 2, 3, 4, and 6 after seeding. Results are expressed as meansSE (n=3) of uptake
values. *P0.05 vs. day 2.D Expression of oNaPi - IIa and oNaPi - IIc protein in OK cells was analyzed by Western blot analysis. PCNA was used
as a cellular marker of cell proliferation. Megalin was used as a marker of the differentiation of proximal tubular cells. Actin was used as an internal
control. E Localization of oNaPi - IIa and oNaPi - IIc in proliferative (2 days) or differentiated (6 days) cells was analyzed by indirect immunofluores-
cence. Cells were fixed and stained with antibody against oNaPi - IIa or oNaPi - IIc and F-actin (Phalloidin). In merged images, oNaPi - IIa and oNaPi -
IIc are shown in green, F-actin is shown in red, and the overlay of both signals is shown yellow. Arrowheads indicate localization of NaPi - IIc pro-
tein with F-actin. The xz cross -section is indicated in the lower panels. F Localization of NaPi - IIc in transiently transfected proliferative OK cells
was analyzed by indirect immunofluorescence. OK cells transfected with FLAG-NaPi - IIc were stained with antibodies against FLAG and F-actin.
In merged images, FLAG-NaPi - IIc is shown in green, F-actin is shown in red, and the overlay of both signals is shown yellow. Arrowheads indicate
localization of NaPi - IIc protein with F-actin. The xz cross -section is indicated in the lower panels.
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Fig. 3
Effects of serum starvation and re- feeding on the expression of oNaPi - IIa and oNaPi - IIc. A Schematic of the experiment schedule. OK cells were
cultured in media with 0.1% bovine serum albumin (serum starvation). After 48 h, media was replaced with DMEM containing 10% FBS (serum re-
feeding), Total cell lysates were prepared every 4 h after medium change. Control cells were cultured in media with 10% FBS, and total lysates were
prepared at days 2 (proliferation) and 4 (differentiation) after seeding. B Cell cycle profiles based on fluorescence-activated cell sorting analysis.
DNA contents in asynchronous cells (cultured with 10% FBS for 2 or 4 days ; proliferative and differentiated cells as controls) and synchronous
cells such as serum-starved cells for 2 days and 24 h after serum re- feeding are shown as histograms (right). Time-course of differentiation rates
of cells at G0/G1 phases and proliferation rates of cells at S+G2/M phases in these DNA profiles are represented by a line graph (left). C Expres-
sion of oNaPi - IIa and oNaPi - IIc under serum starvation or re - feeding conditions was analyzed by Western blot. PCNA was used as a cellular marker
of cell proliferation. Megalin was used as a marker of the differentiation of proximal tubular cells. Actin was used as an internal control. Band den-
sity is normalized against that of actin and expressed as relative intensity to that of the control (+FBS 2 days) levels. MeansSE from two to four
independent experiments performed in duplicate are shown.D Localization of oNaPi - IIa and oNaPi - IIc under serum starvation or re - feeding con-
ditions was analyzed by indirect immunofluorescence. Cells were fixed and stained with antibody against oNaPi - IIa or oNaPi - IIc and F-actin. In
merged images, oNaPi - IIa and oNaPi - IIc are shown in green, F-actin is shown in red, and the overlay of both signals is shown yellow. Arrowheads
indicate localization of oNaPi - IIc protein with F-actin.
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tubules (37). Abnormal endocytosis in the proximal tubules is as-
sociated with mutations of genes such as CLC-5 (chloride/proton
antiporter 5 [Dent’s disease]) and OCRL (oculo-cerebro-renal syn-
drome of Lowe [Lowe syndrome]) (38-41). CLC-5 has a role in
regulating intracellular endosomal pH-dependent activity to ex-
change endosomal luminal H+ for cytosolic 2Cl - (39). CLC-5 KO
mice (Dent’s disease model) exhibit hyperphosphaturia, hypercal-
ciuria, and kidney stones due to endocytic dysfunction (38, 41, 42).
The mutant mice show vitamin D deficiency, but increased vitamin
D synthesis and downregulation of the degradation enzyme of vi-
tamin D in the kidney (37). On the other hand, OCRL mediates
membrane dynamics through PIP2 phosphatase activity (43-46),
and in vitro OCRL mutants failed to regulate intracellular vesicle
transport. OCRL mutations also lead to cellular large vacuoles in
various tissues.
In a previous study, vacuole formation was similar to that re-
ported in ARF6-expressing epithelial cells (34). ARF6 influences
cortical actin structures in the plasma membrane, lending support
to the notion that membrane trafficking influences the composi-
tion and structure of the plasma membrane (34). ARF6 stimulates
protrusion formation in the plasma membrane (34). Activation of
ARF6 also induces the formation of PIP2 -positive actin-coated vacu-
oles that are unable to recycle membrane back to the plasma mem-
brane (34). Overexpressed NaPi-IIc induced intracellular vacuolar
formation and co- localization with PLCδPH-EGFP at the vacuolar
membrane. PIP2 -rich membrane mediates both clathrin-dependent
and independent endocytosis (33, 47), and is required for the up-
take of urinary substrates and regulation of cell surface proteins in
proximal tubular cells (48, 49). We hypothesize that NaPi-IIc is
necessary for PIP2 production and overexpression of NaPi-IIc ac-
tivates ARF6 and enhances PIP2 production. Furthermore, we dem-
onstrated that HHRH mutants (S138F and R468W) do not form
cellular vacuoles, suggesting that HHRH mutations affect PIP2 pro-
duction and vesicle transport.
Finally, in the present study, we are unable to elucidate the physi-
ologic role of oNaPi-IIc in OK cells. The expression patterns of
oNaPi-IIa and oNaPi-IIc were completely reversed during cell pro-
liferation and differentiation. Expression of oNaPi-IIc increased
during cell growth, and oNaPi-IIc localized in intracellular vesicles
and in the membrane protrusion. These localization patterns sug-
gest that NaPi-IIc is involved in cell migration and vesicle traffick-
ing. Exogenous NaPi-IIc expression stimulates cellular vacuole
formation in OK cells, suggesting that NaPi-IIc regulates intracel-
lular vesicle transport by PIP2 production. In addition, the present
data indicate that HHRH mutations may affect PIP2 production
and vesicle transport. Further studies are needed, however, to clar-
ify the mechanisms of cellular vacuole formation by NaPi-IIc.
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Fig. 4
Localization of NaPi - IIc and PLCδ -PH domains (PIP2 marker) in prolif-
erative OK cells was analyzed by indirect immunofluorescence. A Cellu-
lar vacuole formation was observed in OK cells transfected with EGFP-
NaPi - IIa or NaPi - IIc. EGFP-NaPi - IIa or NaPi - IIc is shown in green. B
OK cells transfected with PLCδPH-EGFP were stained with antibodies
against NaPi - IIc. In merged images, oNaPi - IIc is shown in red, PLCδPH-
EGFP is shown in green, and the overlay of both signals is shown yellow.
Arrowheads indicate localization of oNaPi - IIc protein with PLCδPH-
EGFP. C OK cells transfected with PLCδPH-EGFP and mCherry -NaPi -
IIc were observed. In merged images, mCherry -NaPi - IIc is shown in red,
PLCδPH-EGFP is shown in green, and the overlay of both signals is
shown yellow.
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